WallStreetZenWallStreetZen

NASDAQ: INDP
Indaptus Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their INDP stock forecasts and price targets.

Forecast return on equity

Is INDP forecast to generate an efficient return?

Forecast return on assets

Is INDP forecast to generate an efficient return on assets?

Company
-625.42%
Industry
-3.46%
INDP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INDP earnings per share forecast

What is INDP's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$38.66

INDP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INDP$7.81N/AN/A
ADIL$0.40N/AN/A
MTNB$1.65N/AN/A
TRAW$1.62N/AN/A
NLSP$2.61N/AN/A
View Top Biotech Stocks

Indaptus Therapeutics Stock Forecast FAQ

What is INDP's earnings growth forecast for 2025-2025?

(NASDAQ: INDP) Indaptus Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Indaptus Therapeutics's earnings in 2025 is -$16,961,432.

In 2025, INDP is forecast to generate -$42,773,432 in earnings, with the lowest earnings forecast at -$42,773,432 and the highest earnings forecast at -$42,773,432.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.

What is INDP's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: INDP) forecast ROE is N/A, which is considered weak.

What is INDP's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: INDP) Indaptus Therapeutics's current Earnings Per Share (EPS) is -$37.65. In 2025, INDP's EPS is forecast to hit -$38.66 (min: -$38.66, max: -$38.66).

What is INDP's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: INDP) forecast ROA is -625.42%, which is lower than the forecast US Biotechnology industry average of -3.46%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.